Combinatory repair strategy to promote axon regeneration and functional recovery after chronic spinal cord injury

DePaul, Marc A.; Lin, Ching-Yi; Silver, Jerry; Lee, Yu-Shang

doi:10.1038/s41598-017-09432-6

Download PDF

Article
Open access
Published: 21 August 2017

Combinatory repair strategy to promote axon regeneration and functional recovery after chronic spinal cord injury

Marc A. DePaul ORCID: orcid.org/0000-0002-3249-9550¹,
Ching-Yi Lin²,
Jerry Silver¹ &
…
Yu-Shang Lee²

Scientific Reports volume 7, Article number: 9018 (2017) Cite this article

4923 Accesses
34 Citations
1 Altmetric
Metrics details

Subjects

Abstract

Eight weeks post contusive spinal cord injury, we built a peripheral nerve graft bridge (PNG) through the cystic cavity and treated the graft/host interface with acidic fibroblast growth factor (aFGF) and chondroitinase ABC (ChABC). This combinatorial strategy remarkably enhanced integration between host astrocytes and graft Schwann cells, allowing for robust growth, especially of catecholaminergic axons, through the graft and back into the distal spinal cord. In the absence of aFGF+ChABC fewer catecholaminergic axons entered the graft, no axons exited, and Schwann cells and astrocytes failed to integrate. In sharp contrast with the acutely bridge-repaired cord, in the chronically repaired cord only low levels of serotonergic axons regenerated into the graft, with no evidence of re-entry back into the spinal cord. The failure of axons to regenerate was strongly correlated with a dramatic increase of SOCS3 expression. While regeneration was more limited overall than at acute stages, our combinatorial strategy in the chronically injured animals prevented a decline in locomotor behavior and bladder physiology outcomes associated with an invasive repair strategy. These results indicate that PNG+aFGF+ChABC treatment of the chronically contused spinal cord can provide a permissive substrate for the regeneration of certain neuronal populations that retain a growth potential over time, and lead to functional improvements.

Multichannel bridges and NSC synergize to enhance axon regeneration, myelination, synaptic reconnection, and recovery after SCI

Article Open access 18 March 2024

Developmental stage of transplanted neural progenitor cells influences anatomical and functional outcomes after spinal cord injury in mice

Article Open access 19 May 2023

Secretion of a mammalian chondroitinase ABC aids glial integration at PNS/CNS boundaries

Article Open access 09 July 2020

Introduction

The vast majority of research into treatments for spinal cord injury (SCI) focuses predominantly on the acute stages, with far fewer exploring therapies that target the chronically injured cord. Many interventions, including cellular transplantation, promote functional recovery when administered in the acute stages of SCI but ultimately fail when applied chronically^{1, 2}. Repairing a long-standing damaged cord has proven to be a far more challenging goal, as there is dense and well-formed glial scarring around the lesion epicenter and increases in the perineuronal net all along the neuraxis, with both containing abundant levels of inhibitory chondroitin sulfate proteoglycans (CSPGs)^{3, 4}. Unlike acute SCI, chronically injured neurons exist in a persistent dystrophic state having become entrapped in the glial scar and by forming strong synaptic-like connections with CSPG-expressing NG2 cells⁵. In addition, enduring axotomized neurons express low levels of regeneration-associated genes^{6, 7}, resulting in reduced intrinsic regeneration potential. Due to the permanent loss of ascending and descending axonal pathways, chronic demyelination, and the lack of substantial axonal regeneration and plasticity, spontaneous recovery rarely, if ever, occurs in the chronically injured spinal cord^8,9,10.

Certain populations of chronically injured central nervous system (CNS) neurons do, however, retain the ability to regenerate in a highly permissive environment, such as into a graft of support cells made of fetal tissue, peripheral nerves, or olfactory ensheathing cells^{11,12,13,14,15,16,17}. Axonal growth into and along the graft can occur, but most axons fail to exit its distal end, thereby limiting functional recovery. Combining a graft with exogenous neurotrophins, eliminating inhibitory molecules, and/or supplying factors that improve the graft-cord interface can enhance the abundance of axons entering and exiting an acutely applied graft. For example, digestion of CSPG side chains with the bacterial enzyme chondroitinase ABC (ChABC) augments axonal regeneration out of a peripheral nerve graft (PNG) and facilitates recovery^{18, 19}. The digestion of CSPGs also promotes the migration and integration of Schwann cells from the PNG into the host spinal cord²⁰, and allows astrocytes to align tangentially along the injury site²¹. Growth factors such as GDNF, BDNF, NT-3, CNTF, or aFGF applied acutely have been shown to promote axon regeneration into and out of a graft^22,23,24,25. Of particular interest is aFGF, which is essential for the formation of glial bridges upon which regenerating axons cross a lesion to repair injured spinal cords in lower vertebrates²⁶. Mammalian astrocytes treated with aFGF display decreased levels of activation²⁷ and undergo a morphological change from an activated stellate morphology to an elongated bipolar shape, encouraging integration between the PNG and spinal cord^{26, 28}. In a complete transection SCI model, acute repair of the injury through the tripartite combination of PNG, aFGF, and ChABC promoted long-distance axonal regeneration through the PNG and back into the distal cord, restoring supraspinal control of bladder function. Removal of a single factor diminished axonal regeneration and recovery²⁸.

In this study, we investigated a triple combinatorial PNG+aFGF+ChABC treatment paradigm in a more clinically relevant chronic contusion model, where a thick and mature glial scar surrounds a fluid-filled cystic cavity. Within the cavity, we constructed a bridge consisting of multiple intercostal nerve autografts supplemented with ChABC and aFGF. We report here that such a bridging strategy in a chronically contused spinal cord promotes significant integration between the graft and host tissue, allowing catecholaminergic but, interestingly, not serotonergic axons to regenerate beyond the lesion site. While regeneration was more limited than at acute stages, we observed some improvements in locomotor behavior and bladder physiology in chronically injured animals.

Results

Experimental design

Contusive injury is the most common form of SCI affecting humans²⁹. We modeled this injury in rodents using the Infinite Horizon device by delivering a controlled impact (250 kDyne) to the spinal cord at thoracic level 8 (T8). Over the course of weeks, a fluid-filled, scar-encased, cystic cavity forms at the injury site (Fig. 1a,b). Eight weeks following the initial injury, animals were randomly placed into one of three groups: PNG, aFGF+ChABC, or PNG+aFGF+ChABC. In all animals, a gentle incision (~2 to 3 mm) was made in the dorsal part of the spinal cord near the injury site to expose the cavity. Mature scar tissue was gently removed manually in multiple pieces from the cavity wall. One cohort of animals received injections of aFGF+ChABC with no PNG and another received aFGF+ChABC with a PNG. A third group received a PNG with only saline injections. In the two PNG groups, two to four intercostal nerve segments were collected, soaked in ChABC, and then placed in the lesion cavity to create an autologous PNG bridge (Fig. 1a).

Catecholaminergic axons, but not serotonergic axons, regenerate through the peripheral nerve graft and back into the distal cord

Our previous acute study revealed that both serotonergic (5-HT+) and tyrosine hydroxylase (TH+) axons regularly regenerated into and out of the PNG when the PNG+aFGF+ChABC paradigm was administered immediately following an injury²⁸. In the chronically injured spinal cord, it was not known whether these populations of neurons retain the ability to regenerate. Thirty-two weeks following the chronic repair, the PNG+aFGF+ChABC group had robust regeneration of catecholaminergic axons, identified by being TH+ (Fig. 2a–c) and norepinephrine transporter-positive (NET+) (Fig. 2d,e). Axons could be seen entering the proximal nerve graft (Fig. 2b,d), traveling for long distances through the PNG, and crossing the PNG/spinal cord interface well into the glial fibrillary acidic protein-positive (GFAP+) host spinal cord (Fig. 2c,e). NET+ expression, which is restricted to noradrenergic neurons and is not present in neurons that release dopamine or epinephrine^{30, 31}, closely mirrored TH+ staining. The PNG/saline group, which lacked aFGF and ChABC, displayed a similar density of TH+ axons as the triple combination group in the cord at the rostral graft interface (Fig. 2f,g,i). In this control group TH+ axons still frequently entered the graft, albeit at a significantly lower density than the triple combination group (Fig. 2b,g,i). However, the axons remained in the graft, never crossing the caudal interface back into the spinal cord (Fig. 2f,h,i). These results illustrate the importance of aFGF and ChABC in facilitating axonal entry into the graft, and more importantly, axonal re-entry back into the spinal cord.

Conversely, in both the PNG and PNG+aFGF+ChABC groups, lower densities of serotonergic neurons, identified as 5-HT+ or serotonin transporter-positive (SERT+), regenerated into the graft (Fig. 3a,b,d–f,h). The PNG+aFGF+ChABC group displayed a modest but significant increase in 5-HT+ axons in the graft compared to the PNG group; however, we did not observe serotonergic axons re-entering the cord from the distal end of the graft (Fig. 3c,g,h). These results suggest that in the chronically injured spinal cord, catecholaminergic axons retain the ability to regenerate robustly into and out of a peripheral nerve graft, while serotonergic axons have a markedly reduced ability to regenerate in our model.

aFGF and ChABC combined with the PNG promote astrocyte and Schwann cell integration at chronic stages

The abundance of TH+ axons growing into, but especially out of, the graft resulting from the addition of aFGF and ChABC suggested that these factors may influence how Schwann cells from the graft interact with resident reactive astrocytes in the host spinal cord. Therefore, we examined the shapes of these two populations of glial cells and the extent of overlap at the graft–host interface following PNG or PNG+aFGF+ChABC treatment. Spinal cords containing only a PNG displayed distinct boundaries between GFAP+ astrocytes and low-affinity nerve growth factor receptor, P75-positive (P75+) Schwann cells, creating a sharp border between the two cell types with no overlapping spatial domains. Astrocytes that remained close to the PNG/cord interface had migrated minimally into the graft (Fig. 4, left column). Conversely, the addition of aFGF and ChABC promoted remarkable astrocyte and Schwann cell migration and robust intermingling of the two cell types (Fig. 4, right column). Astrocytes migrated long distances throughout the entire graft and Schwann cells migrated far into the spinal cord (Fig. 4, right column). Unlike the PNG only animals, astrocytes and Schwann cells often occupied the same spatial domains, appearing as double-labeled points in confocal z-stacks (Fig. 4, right column). Furthermore, astrocyte processes, as well as Schwann cell processes, were predominantly aligned parallel to axonal processes along the longitudinal axis. These results indicate that the addition of aFGF and ChABC to the PNG/spinal cord interface enhances Schwann cell-astrocyte integration and suggest that this integration helps facilitate axon regeneration out of the graft back into the caudal spinal cord.

The raphe, but not the locus coeruleus, increases suppressor of cytokine signaling 3 (SOCS3) expression following chronic SCI

Chronically injured TH+, but not 5-HT+, neurons retain the ability to robustly regenerate in our triple combination therapy, suggesting that differences exist in how these two neuronal populations respond to contusive injury over time. We, therefore, examined the locus coeruleus and raphe, regions of the brainstem respectively housing TH+ (Fig. 5a) and 5-HT+ (Fig. 5b) somata, for expression changes of intrinsic factors known to control axon re-growth. Prior to the injury, both the locus coeruleus and raphe expressed low levels of SOCS3 (Fig. 5c,d), an important negative regulator of injury-induced growth-promoting factors³². By eight weeks post injury (wpi), at the time of the second repair surgery, a strong and persisting upregulation of SOCS3 was observed in the raphe, which was maintained until the end of the study at 40 wpi (Fig. 5d). On the other hand, SOCS3 expression in the locus coeruleus remained low at all observed time points (Fig. 5c). SOCS3 expression at 6 months post injury without a second surgical intervention was elevated in the raphe but not the locus coeruleus, similar to what we observed following the triple combinatorial treatment, suggesting that neither the second surgery nor the treatment affect SOCS3 expression (data not shown). Several studies have also identified that activation of the mammalian target of rapamycin/phosphatase and tensin homolog (mTOR/PTEN) pathway inhibits axon regeneration^{33, 34}. We found no evidence of mTOR/PTEN activation as uninjured rats displayed similar levels of phosphorylated S6 (pS6) in the locus coeruleus and raphe, which did not change noticeably in their injured counterparts at 8 wpi or 40 wpi (Fig. 5e,f). This data suggests that SOCS3 expression in the locus coeruleus and raphe negatively correlates with the growth potential of these two systems and may contribute to regeneration or sprouting failure of chronically injured 5-HT+ neurons in the spinal cord.

PNG+aFGF+ChABC increases lumbar TH+ axons around the anterior horn of the spinal cord

The caudal spinal cord houses second order efferent neurons and interneurons critical for the control of locomotion and micturition. Noradrenergic and serotonergic neurons have been shown to be important modulators of both locomotor^{35, 36} and bladder^{37, 38} function. We next examined the lumber cord for the presence of 5-HT+ and TH+ axons within the ventral horn. All injured groups showed a decrease in TH+ and 5-HT+ axon densities compared to the uninjured naive cord; however, the PNG+aFGF+ChABC-treated animals displayed a relative increase in TH+ density when compared to the PNG or aFGF+ChABC treatment groups (Fig. 6a,b). All injured groups displayed similar low 5-HT+ levels regardless of treatment conditions (Fig. 6a,c). These results are consistent with the observed TH+ axon regeneration and the lack of 5-HT+ axon regeneration at the thoracic injury site following PNG+aFGF+ChABC treatment (Figs 2 and 3) and suggest that in the chronic state of SCI the triple combination treatment may promote long distance regeneration or sprouting of spared axons distal from the injury site in certain neural populations.

PNG+aFGF+ChABC maintains locomotor skills and improves lower urinary tract recovery after chronic injury

SCI often results in the permanent decline of locomotor and lower urinary tract function. We tracked locomotor recovery prior to and following the repair surgery using the Basso, Beattie and Bresnahan (BBB) scale³⁹. Eight weeks post-injury and prior to the repair surgery, all animals were able to weight-support step, corresponding to a BBB score of 10–11 (Fig. 7a). Following the repair surgery, the PNG and aFGF+ChABC control groups lost the ability to weight-support step (BBB < 10). However, animals treated with PNG+aFGF+ChABC maintained the ability to occasionally weight-support step (Fig. 7a). PNG+aFGF+ChABC treatment maintained significantly better BBB walking scores than the aFGF+ChABC and PNG treatment groups beginning at about eight weeks or 16 weeks post-repair surgery, respectively, and continuing until the end of the study (Fig. 7a). These results suggest that PNG+aFGF+ChABC treatment did not lead to robust recovery of walking, but rather attenuated the decline in locomotor ability that develops following an invasive repair surgery.

Lower urinary tract dysfunction is a major concern among the spinal cord-injured population⁴⁰. In humans, SCI-induced urinary retention is treated by catheterization, which severely lowers the quality of life and contributes to urinary tract infections. Following SCI, micturition patterns in rats shift to fewer and larger voids, quantified using metabolic cage recordings (Fig. 7b). Prior to the repair surgery, all groups displayed a similar void frequency and volume (Fig. 7c,d). Following the repair surgery, PNG+aFGF+ChABC treatment significantly improved void frequency beyond that of the pre-repair rate and also beyond that in the two control groups (Fig. 7b,c). No changes were observed in void volume (Fig. 7b,d). Next, we investigated the coordinated recovery of muscles controlling micturition at 40 weeks post-injury using terminal urodynamic analyses. During a normal voiding event in a non-spinalized rat, the external urethral sphincter (EUS) phasically bursts in coordination with a detrusor contraction, expressing urine out of the bladder through the urethra. Most EUS bursts occur between the opening peak pressure and closing peak pressure of a bladder contraction, outlined in grey boxes in Fig. 8a–c. Following injury, coordination between the EUS and detrusor is lost, resulting in bladder contractions against a closed urethra and inappropriately timed EUS bursting. All but one rat in the aFGF+ChABC group retained the basic ability to burst (Fig. 8d,e). PNG- and PNG+aFGF+ChABC-treated animals displayed more bursts per void than the aFGF+ChABC group (Fig. 8d,f). However, only in the PNG+aFGF+ChABC-treated animals were the majority of bursts synchronized between the opening and closing peak pressure of a bladder contraction (Fig. 8d,g). Improved coordination led to an increased voiding efficiency and decreased residual volume (Fig. 8h). Following SCI, the bladder enlarges and distends to accommodate a larger capacity of urine due to inefficient voiding. The bladders of animals treated with PNG+aFGF+ChABC were smaller (Fig. 8i), elicited a void at a smaller volume (Fig. 8j), and generated a greater pressure difference during the void, indicating a smaller and stronger bladder. These results suggest that PNG+aFGF+ChABC treatment delivered during the chronic stage after SCI improves bladder-EUS synchrony, resulting in voids that are more efficient and a healthier bladder.

Discussion

Substantial barriers exist to inhibit axonal regeneration that could lead to functional recovery after chronic SCI. The lesion environment is densely scarred and laden with inhibitors³, the surviving neurons decline in their intrinsic ability to grow^{6, 7}, and persistent inflammation hinders proper wound healing⁴¹. Many therapies developed to treat acute stages of SCI, such as immune modulation⁴² or inhibition of scar formation⁴³, will not translate to injuries in more chronic states. While we previously showed that our triple combination repair strategy consisting of PNG+aFGF+ChABC promoted the regeneration of acutely lesioned axons into, and most importantly, out of grafts^{28, 44}, it was unknown whether this strategy might also be efficacious in the chronically injured state. In the current study, we utilized a contusion injury, the most common type of SCI²⁹, rather than a full transection injury used in the acute models. We report here, for the first time, that treatment of a chronically contused spinal cord with PNG+aFGF+ChABC promotes significant integration between PNG Schwann cells and reactive astroglia of the cord which, in turn, allows noradrenergic but not serotonergic axons to regenerate. Additionally, this treatment lead to functional improvements, especially in bladder physiology.

It has long been known that axons can readily grow into a PNG^45,46,47; however, almost no axons will cross from the PNG through a glial scar back into the CNS without additional manipulations⁴⁶. We addressed this regeneration shortfall through the removal of inhibitory CSPGs at the graft/host interface, by supplying trophic support to promote lengthy axonal growth, and by enhancing integration between the graft and spinal cord glia.

ChABC and aFGF’s contribution to regeneration

ChABC digestion of CSPGs enhances axonal regeneration and sprouting in a variety of injury models^{8, 18, 19, 48, 49}. The addition of ChABC to a PNG repair model resulted in significantly more axons crossing the graft/cord interface and improved functional recovery^{19, 28}. Axonal growth is also enhanced through aFGF stimulation. FGF has been shown to promote long-distance, unbranched axon regrowth^{50, 51}, in contrast to other neurotrophins such as NGF, BDNF, or neurotrophin-3, which promote a more branched pattern of growth that may hinder rectilinear elongation⁵². However, since a contused spinal cord contains spared fibers, other possible mechanisms beyond regeneration from injured axons, such as sprouting of uninjured tracts⁵³, activation of redundant or latent pathways⁵⁴, and alterations to postsynaptic receptors or activation thresholds⁵⁵, cannot be excluded from contributing to recovery.

ChABC and aFGF’s contribution to the graft/cord interface

Our results have also shown that the addition of aFGF and ChABC to the PNG in a chronically injured cord strongly promotes astrocyte orientation towards and migration well into the Schwann cell-laden graft, and vice versa. A characteristic feature of successful tissue repair between the PNG and CNS compartment is the integration of donor and host glia. Bridge building by astrocytes, even when they are in a fully reactive state, has been described as an anatomical predictor of axon regeneration across lesions^{56,57,58,59,60,61,62}. Several studies with successful axon regeneration into or through peripheral nerve repair grafts exhibit integrating migration of astrocytes and Schwann cells at the graft/cord interface^{58, 63,64,65,66,67}, whereas a lack of integration is associated with regeneration failure^{58, 67, 68}. In our chronic contusion model, astrocyte/Schwann cell interactions were surprisingly enhanced even beyond that which occurs at acute stages by the addition of aFGF and ChABC. In mammals, aFGF has frequently been shown to reduce axonal die-back, to promote regeneration through a graft, and to reduce astrocyte reactivity^{24, 25, 27, 69, 70}. Interestingly, FGF signaling is also crucial for the formation of astrocyte bridges, upon which regenerating axons cross a transected zebrafish spinal cord²⁶. Both zebrafish and human astrocytes undergo a dramatic transformation from a stellate shape to a bipolar, radial morphology upon aFGF stimulation²⁶, bearing a remarkable resemblance to the long, fingerlike astrocytic projections in successful grafts observed here and previously^{28, 66}. Failure to include aFGF in a PNG or Schwann cell graft significantly diminishes the abundance of regenerating axons found within the graft^{28, 71}. While more evidence exists for the role of aFGF in graft/cord interface integration, ChABC digestion of CSPGs may also contribute to the improved interface by reducing basal lamina formation thereby facilitating the migration of Schwann cells into the host spinal cord²⁰, as well as aligning and allowing for reverse migration of astrocytes towards and into the graft site²¹. While we did not investigate the effects of ChABC or aFGF individually in this current chronic study, our previous acute study suggests that leaving out either aFGF or ChABC severely diminishes the prevalence of regenerating axons and disrupts the PNG/cord interface²⁸.

Removal of the glial scar

Following contusion injury, the scar which is comprised of multiple layers of densely packed and highly reactive astrocytes lined by a population of collagen producing reactive pericytes forms a smooth surface facing the cavity^72,73,74. Removal of the scar prior to transplantation has been reported by others to improve graft/cord integration⁷⁵ and to enhance regeneration^{15, 76}. In this study, in order to permit graft apposition with the cord parenchyma, we gently extracted the mature scar tissue lining the injury cavity. Scar removal may promote an acute-injury response and/or the removal of physical and biochemical hindrances, thereby enhancing integration. Thus, it is possible that, while minimally invasive, removal of this layer helped to trigger plastic changes in chronically reactive astrocytes lying slightly deeper which, in turn, may have allowed their enhanced integration with Schwann cells. However, the molecular mechanisms that lead to such far-ranging mixing of the two cell types in the chronic state, and how aFGF+ChABC facilitates this integration, remains to be elucidated. Further, it is unknown if aFGF+ChABC is sufficient for integration in the absence of scar removal.

The regeneration potential of chronically injured 5-HT+ and TH+ axons

A major observation of this study is the contrasting regeneration potential of different chronically injured neuronal populations. When our triple combination treatment was applied immediately following injury, a time at which SOCS3 expression is low in both the raphe and locus coeruleus, both 5-HT+ and TH+ axons robustly regenerated through the PNG and back into the distal cord²⁸. However, in the chronic state, only TH+ axons regenerated in appreciable densities, whereas 5-HT+ neurons, which strongly increased SOCS3 expression, failed to re-grow. Others have reported limited regeneration of serotonergic axons in the chronic injury^{14, 66, 77, 78}. Similar to our observation, these studies described 5-HT axons growing into a graft or lesion epicenter, but did not show regeneration out of the graft or into the distal cord. The decrease in regenerative potential appears to be time-dependent, as 5-HT axons are still capable of regeneration through a fetal spinal transplant in the sub-acute stage at two weeks post-injury⁷⁹. The contribution of SOCS3 expression to, and how it is impacting, regeneration failure in the chronic injury state remains to be determined experimentally. Indeed, SOCS3 may only be one among several factors at play; including upregulation of other intrinsic growth-regulatory genes⁸⁰, as well as increased expression or signaling of receptors that recognize extrinsic inhibitory molecules, such as myelin or CSPGs^{81, 82}. However, the lack of expression changes observed in mTOR/PTEN indicates that the SOCS3 pathway may play a more important role in regulating nerve regeneration from brainstem neurons. Further investigation is also needed to determine whether other populations of acutely regenerating axons, such as propriospinal or dorsal column axons, retain or lose their regenerative capacity over time.

Bladder recovery following PNG+aFGF+ChABC treatment

A leading factor affecting the quality of life of individuals living with SCI is bladder control⁴⁰. We observed significant, albeit modest, improvements in lower urinary tract recovery with PNG+aFGF+ChABC treatment that were especially correlated with improved bursting synchrony between the EUS and bladder detrusor. While EUS bursting activity in general is known to be modulated by 5-HT in the lumbosacral spinal cord^{38, 83, 84}, we observed very little 5-HT regeneration or sprouting in the thoracic or lumbar segments in any of the groups. This could be the likely explanation for the consistently low levels of bursting for most animals regardless of treatment. Nonetheless, as a group, PNG+aFGF+ChABC animals displayed greater EUS-bladder synchrony, lower residual volume, smaller overall bladders, and a greater frequency of voiding, suggesting that the TH+ system or other unidentified tracts also play a role in the recovery of lower urinary tract function, as we have observed in the acute treatment paradigm^{28, 44}. While physiological recovery was correlated to regeneration, we cannot discount how the PNG+aFGF+ChABC treatment may be acting on intact tracts to promote compensatory sprouting and the return of function.

The current study provides an experimental framework for the treatment of a long-standing contusive SCI. The transplantation of peripheral nerve autografts supplemented with aFGF and ChABC promoted axonal regeneration by chronically injured neurons and provided an avenue to improve locomotor and bladder function. Future challenges will be to target neuronal populations that fail to grow in the chronic state by either creating even more favorable environments⁸⁵ or by targeting intrinsic growth programs such as SOCS3. However, it is evident by this work and others that a combination of approaches targeting many aspects of SCI pathology will most likely be needed.

Methods

Study design

Thirty-three Sprague-Dawley rats (225–250 g) underwent a 250 kdyne contusion at vertebral T8. Eight weeks post-injury, rats with a BBB score of 10 or greater (range 10–11) were randomly assigned into three groups (n = 24) and underwent a second surgery: PNG, aFGF+ChABC, or PNG+aFGF+ChABC. Animals were then observed for 32 additional weeks. During this time, any rats developing health complications were removed from the study (2 in each group). Each rat reaching the study endpoint was included in the data analysis. The final group size is n = 6 per group. Locomotor assessments were evaluated with the BBB open field locomotor test performed monthly. Bladder assessments were performed by metabolic cage analysis prior to the second surgery and monthly thereafter. Cystometric analysis with EUS EMG recording was performed 40 weeks post-injury, followed by sacrifice and histological investigation in both brain and spinal cord. Another cohort of 4 naïve animals were also sacrificed for histological comparisons.

Contusive spinal cord surgery, multiple peripheral nerve segment transplantation, and aFGF+ ChABC injection

All sterile surgical procedures were performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Institutional Care and Use Committee of both the Case Western Reserve University animal resource center and the Cleveland Clinic. Adult female Sprague-Dawley rats (225–250 g) were obtained from Harlan/Envigo and acclimated to the animal resource center, behavior analysis chambers, and handlers. Rats were intraperitoneally injected with ketamine (60 mg/kg) and xylazine (10 mg/kg). The musculature was cut from T7-T9 and the dorsal surface of T8 was exposed by laminectomy. The vertebral column was stabilized by clamping the T7 and T9 vertebral bodies with forceps fixed to the base of the Infinite Horizon Impact Device. The animals were situated on the platform and the 2.5mm stainless steel impactor tip was positioned over the midpoint of T8 and impacted with 250 kDyne force. The overlying musculature was sutured closed and the skin was closed using wound clips. The animals were treated with Marcaine at the incision site. A force/displacement graph was used to monitor impact consistency and any animals that exhibited an abnormal impact graph or greater than 10% deviation from 250kDyne were immediately excluded from the study (n = 0). Manual bladder expression was performed 2–3 times daily for two-three weeks until a voiding reflex returned. Eight weeks following the contusive SCI, a second surgery was performed under 2% isoflurane mixed with oxygen anesthesia. The thoracic spinal cord was re-exposed and the dorsal spinal cord was incised to expose the underlying cavity. Scar tissue was gently teased out of the cavity. Two μl (0.5 μl at the rostral and caudal lesion, and 0.5 µl on the lateral sides of the lesion) of saline or 1:1 ChABC (1U/ml) & aFGF (10 μg) mixture was injected into the spinal cord via a Nanoject II (Drummond Scientific Company). For the PNG and PNG+aFGF+ChABC groups, the intercostal nerves were collected, soaked in ChABC (1U/ml) or saline for 30 min, and then two to four PNG bridges were constructed from segments spanning the lesion. The graft was supported using an aFGF/ChABC/fibrin glue. Monofilament sutures (4-0) were used to close the skin and musculature. Bladders were manually expressed twice per day until a voiding reflex returned.

Behavioral analyses of locomotion and bladder function

BBB open field locomotor assessment

Blinded observers conducted all behavioral analyses. BBB score was performed as described previously³⁹. Each animal was tested prior to the second surgery and monthly thereafter, through week 40.

Metabolic cage micturition

Prior to the second surgery and monthly thereafter, animals were placed overnight in a metabolic cage (Braintree Scientific) with access to ample food and water for the measurement of voiding patterns. Urine was collected on a force transducer and strain gauge (Grass Technologies) and plotted in Spike2 (Cambridge Electrical Design, sampled at 20HZ). Micturition pattern analysis included the frequency of voiding in a 16-hour period and the volume per void. The total volume of expelled urine was not included because of variation in water intake between individual animals.

Urodynamics

Terminal urodynamic recordings were performed as described previously²⁸. Briefly, rats were anesthetized at 40 weeks post-SCI with 0.8 g/kg urethane delivered subcutaneously. A polyethylene-50 catheter was carefully inserted through the urethra into the bladder for the delivery of saline. Fine-wire electrodes (0.003″ diameter Teflon-insulated silver wire; A-M Systems) were inserted percutaneously via the vagina on both sides of the urethra to monitor EUS electromyography (EMG) activity. The electrodes were connected to a preamplifier (HZP; Grass-Technologies), which was connected to an amplifier (QP511, Grass-Technologies) with high- and low-pass frequency filters at 30 Hz and 3 kHz and a recording system (Power 1401, Spike2; Cambridge Electronic Design) at a sampling frequency of 10 kHz. Continuous cystometrograms (CMGs) were collected using constant infusion (6 ml/hr) of room temperature saline (Aladdin-1000 single syringe infusion pump; World Precision Instruments) through the catheter into the bladder to elicit repetitive voids. The bladder pressure was recorded via the same catheter used for saline infusion, using a pressure transducer (P23XL, Grass Technologies) connected to strain gauge (P11T, Grass Technologies), which fed into the recording system and sampled at 2 kHz. Quantification of bursting was completed using Spike2 and EXCEL (Microsoft). The timestamp of the opening peak pressure (OPP) and closing peak pressure (CPP) were measured and assigned a value from 0 to 100 (0–100%), respectively, to normalize the length of time between the OPP and CPP between animals and when bursting occurred. Bursting timestamp was then marked via custom Spike2 scripts and given a percentage value as to when the burst occurred based on the corresponding OPP and CPP timestamps.

Perfusion and immunohistochemistry

Rats were transcardially perfused with ice-cold 4% paraformaldehyde in PBS and the spinal cords and bladders were dissected. The tissue was post-fixed in 4% paraformaldehyde overnight at 4 °C and then cryoprotected with 30% sucrose. Spinal cords and brains were then frozen in OCT mounting media and sectioned on a Hacker cryostat at a thickness of 30 µm. Free-floating sections were washed three times with PBS followed by blocking in 3% normal goat serum (NGS) or normal donkey serum (NDS) and 1% bovine serum albumin (BSA) in PBS. 0.25% Triton-X was added to the blocking buffer depending on the antigen used. Following blocking, sections were incubated in primary antibody diluted in blocking buffer overnight at room temperature. Primary antibodies used were anti-TH polyclonal antibody (1:1000 dilution; Protos Biotechnology), anti-5-HT polyclonal antibody (1:1500 dilution; DiaSorin), anti-GFAP antibody (1: 4000 dilution; EMD Millipore), anti-SOCS3 antibody (1:1000 dilution; Abcam), anti-pS6 antibody (1:7500 dilution; Cell Signaling Technology), anti-NET antibody (1:500; EMD Millipore), anti-SERT antibody (1:1000 dilution; Calbiochem), or anti-p75 antibody (1:1000 dilution; Abcam). After 3 rinses (10 mins per time) in PBS, sections were incubated with species-appropriate secondary antisera conjugated with Alexa Fluor 594 or Alexa Fluor 488 (Invitrogen/Molecular Probes) for 90 min, washed for 3 times (10 mins per time), mounted on the slides, and then coverslipped with Vectashield (Vector Laboratories Inc., Burlingame, CA, USA). All sections were examined using a Leica DM5000 fluorescent microscope with deconvolution, and the distribution of TH and 5-HT fibers was analyzed in multiple parallel sections. Further images were collected using a Carl Zeiss LSM 510META confocal microscope or Leica SP8 confocal microscope.

Pixel density analysis

Color images of interest obtained via fluorescent microscopy under identical exposure settings. Images were then converted to a grayscale prior to pixel intensity analysis. Grayscale follows an index between 0–255 (black-white) with an index of 0 and 255 corresponding to background and maximum expression under fixed microscopy settings, respectively. A custom MATLAB program was written to normalize the image background to an index of 0 (black), and calculate the area of positive expression as the number of pixels exceeding the background threshold index within the image frame. The number of positive pixels was then divided by the total number of pixels to obtain the pixel density.

Data analysis

All statistical analyses were performed using Prism (Graphpad) and were considered significant when p < 0.05. All results are presented as mean ± s.e.m. D’Agostino–Pearson and Shapiro–Wilk tests were first performed to determine normality of data. For TH+ and 5-HT+ regeneration in the thoracic cord, a 2-tailed Student’s T-test was performed. For BBB score and metabolic cage analyses, two-way repeated measures ANOVAs were performed to compare between all injured groups from weeks 16–40. Post-hoc analyses between different treatment groups at individual time points were performed with Fisher’s Least Significant Difference post-hoc test. To compare within a group, an ANOVA was performed with Fisher’s Least Significant Difference post-hoc test to compare pre-repair surgery values with post-repair surgery values. Urodynamic data and lumbar immunoreactivity were evaluated via ANOVAs between injured groups with Fisher’s Least Significant Difference post-hoc test.

References

Houle, J. D. & Tessler, A. Repair of chronic spinal cord injury. Exp Neurol 182, 247–260 (2003).
Article PubMed Google Scholar
Tetzlaff, W. et al. A systematic review of cellular transplantation therapies for spinal cord injury. J Neurotrauma 28, 1611–1682 (2011).
Article PubMed PubMed Central Google Scholar
Cregg, J. M. et al. Functional regeneration beyond the glial scar. Exp Neurol 253, 197–207 (2014).
Article PubMed Google Scholar
Andrews, E. M., Richards, R. J., Yin, F. Q., Viapiano, M. S. & Jakeman, L. B. Alterations in chondroitin sulfate proteoglycan expression occur both at and far from the site of spinal contusion injury. Exp Neurol 235, 174–187 (2012).
Article CAS PubMed Google Scholar
Busch, S. A. et al. Adult NG2+ cells are permissive to neurite outgrowth and stabilize sensory axons during macrophage-induced axonal dieback after spinal cord injury. Journal of Neuroscience 30, 255–265 (2010).
Article CAS PubMed PubMed Central Google Scholar
Storer, P. βIi-tubulin and GAP 43 mRNA expression in chronically injured neurons of the red nucleus after a second spinal cord injury. Exp Neurol 183, 537–547 (2003).
Article CAS PubMed Google Scholar
Tetzlaff, W., Alexander, S. W., Miller, F. D. & Bisby, M. A. Response of facial and rubrospinal neurons to axotomy: changes in mRNA expression for cytoskeletal proteins and GAP-43. J Neurosci 11, 2528–2544 (1991).
CAS PubMed Google Scholar
Bradbury, E. J. et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416, 636–640 (2002).
Article ADS CAS PubMed Google Scholar
Totoiu, M. O. & Keirstead, H. S. Spinal cord injury is accompanied by chronic progressive demyelination. J Comp Neurol 486, 373–383 (2005).
Article PubMed Google Scholar
Massey, J. M. et al. Chondroitinase ABC digestion of the perineuronal net promotes functional collateral sprouting in the cuneate nucleus after cervical spinal cord injury. Journal of Neuroscience 26, 4406–4414 (2006).
Article CAS PubMed Google Scholar
Houle, J. D. & Reier, P. J. Transplantation of fetal spinal cord tissue into the chronically injured adult rat spinal cord. J Comp Neurol 269, 535–547 (1988).
Article CAS PubMed Google Scholar
Houle, J. D. & Reier, P. J. Regrowth of calcitonin gene-related peptide (CGRP) immunoreactive axons from the chronically injured rat spinal cord into fetal spinal cord tissue transplants. Neurosci Lett 103, 253–258 (1989).
Article CAS PubMed Google Scholar
Lu, J., Féron, F., Mackay-Sim, A. & Waite, P. M. E. Olfactory ensheathing cells promote locomotor recovery after delayed transplantation into transected spinal cord. Brain 125, 14–21 (2002).
Article PubMed Google Scholar
Barakat, D. J. et al. Survival, integration, and axon growth support of glia transplanted into the chronically contused spinal cord. Cell Transplant 14, 225–240 (2005).
Article CAS PubMed Google Scholar
Houle, J. D. Demonstration of the potential for chronically injured neurons to regenerate axons into intraspinal peripheral nerve grafts. Exp Neurol 113, 1–9 (1991).
Article CAS PubMed Google Scholar
Tom, V. J. et al. Combining peripheral nerve grafts and chondroitinase promotes functional axonal regeneration in the chronically injured spinal cord. Journal of Neuroscience 29, 14881–14890 (2009).
Article CAS PubMed PubMed Central Google Scholar
Bretzner, F., Liu, J., Currie, E., Roskams, A. J. & Tetzlaff, W. Undesired effects of a combinatorial treatment for spinal cord injury - transplantation of olfactory ensheathing cells and BDNF infusion to the red nucleus. European Journal of Neuroscience 28, 1795–1807 (2008).
Article PubMed Google Scholar
Houle, J. D. et al. Combining an autologous peripheral nervous system ‘bridge’ and matrix modification by chondroitinase allows robust, functional regeneration beyond a hemisection lesion of the adult rat spinal cord. Journal of Neuroscience 26, 7405–7415 (2006).
Article CAS PubMed Google Scholar
Alilain, W., Horn, K. P., Hu, H., Dick, T. E. & Silver, J. Functional regeneration of respiratory pathways after spinal cord injury. Nature 475, 196–200 (2011).
Article CAS PubMed PubMed Central Google Scholar
Grimpe, B. et al. The role of proteoglycans in Schwann cell/astrocyte interactions and in regeneration failure at PNS/CNS interfaces. Mol. Cell. Neurosci. 28, 18–29 (2005).
Article CAS PubMed Google Scholar
Milbreta, U. et al. Astrocytic and vascular remodeling in the injured adult rat spinal cord after chondroitinase ABC treatment. J Neurotrauma 31, 803–818 (2014).
Article PubMed PubMed Central Google Scholar
Deng, L.-X. et al. A novel growth-promoting pathway formed by GDNF-overexpressing Schwann cells promotes propriospinal axonal regeneration, synapse formation, and partial recovery of function after spinal cord injury. Journal of Neuroscience 33, 5655–5667 (2013).
Article CAS PubMed PubMed Central Google Scholar
Ye, J. H. & Houle, J. D. Treatment of the chronically injured spinal cord with neurotrophic factors can promote axonal regeneration from supraspinal neurons. Exp Neurol 143, 70–81 (1997).
Article CAS PubMed Google Scholar
Cheng, H., Cao, Y. & Olson, L. Spinal cord repair in adult paraplegic rats: partial restoration of hind limb function. Science 273, 510–513 (1996).
Article ADS CAS PubMed Google Scholar
Lee, Y.-S., Baratta, J., Yu, J., Lin, V. W. & Robertson, R. T. aFGF promotes axonal growth in rat spinal cord organotypic slice co-cultures. J Neurotrauma 19, 357–367 (2002).
Article PubMed Google Scholar
Goldshmit, Y. et al. Fgf-dependent glial cell bridges facilitate spinal cord regeneration in zebrafish. Journal of Neuroscience 32, 7477–7492 (2012).
Article CAS PubMed Google Scholar
Kang, W. et al. Astrocyte activation is suppressed in both normal and injured brain by FGF signaling. Proc Natl Acad Sci USA 111, E2987–95 (2014).
Article CAS PubMed PubMed Central Google Scholar
Lee, Y.-S. et al. Nerve regeneration restores supraspinal control of bladder function after complete spinal cord injury. Journal of Neuroscience 33, 10591–10606 (2013).
Article CAS PubMed PubMed Central Google Scholar
Van Leeuwen, F. W., Salehi, A., Giger, R. J., Holtmaat, A. J. G. D. & Verhaagen, J. eds Neuronal Degeneration and Regeneration: From Basic Mechanisms to Prospects for Therapy: Proceedings of the 20^th International Summer School of Brain Research, Held at the Royal Netherlands Academy of Sciences, Amsterdam, The Netherlands from 25 to 29 August 1997. Progress in brain research 117, 1–532 (1998).
Schroeter, S. et al. Immunolocalization of the cocaine- and antidepressant-sensitive l-norepinephrine transporter. J Comp Neurol 420, 211–232 (2000).
Article ADS CAS PubMed Google Scholar
Torres, G. E., Gainetdinov, R. R. & Caron, M. G. Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci 4, 13–25 (2003).
Article CAS PubMed Google Scholar
Smith, P. D. et al. SOCS3 deletion promotes optic nerve regeneration in vivo. Neuron 64, 617–623 (2009).
Article CAS PubMed PubMed Central Google Scholar
Park, K. K. et al. Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 322, 963–966 (2008).
Article ADS CAS PubMed PubMed Central Google Scholar
Park, K. K., Liu, K., Hu, Y., Kanter, J. L. & He, Z. PTEN/mTOR and axon regeneration. Exp Neurol 223, 45–50 (2010).
Article CAS PubMed Google Scholar
Chau, C., Barbeau, H. & Rossignol, S. Effects of intrathecal alpha1- and alpha2-noradrenergic agonists and norepinephrine on locomotion in chronic spinal cats. Journal of Neurophysiology 79, 2941–2963 (1998).
CAS PubMed Google Scholar
Schmidt, B. J. & Jordan, L. M. The role of serotonin in reflex modulation and locomotor rhythm production in the mammalian spinal cord. Brain Res Bull 53, 689–710 (2000).
Article CAS PubMed Google Scholar
Woods, M., Carson, N., Norton, N. W., Sheldon, J. H. & Argentieri, T. M. Efficacy of the beta3-adrenergic receptor agonist CL-316243 on experimental bladder hyperreflexia and detrusor instability in the rat. J Urol 166, 1142–1147 (2001).
Article CAS PubMed Google Scholar
Dolber, P. C. et al. Activation of the external urethral sphincter central pattern generator by a 5-HT(1A) receptor agonist in rats with chronic spinal cord injury. Am J Physiol Regul Integr Comp Physiol 292, R1699–706 (2007).
Article CAS PubMed Google Scholar
Basso, D. M., Beattie, M. S. & Bresnahan, J. C. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12, 1–21 (1995).
Article CAS PubMed Google Scholar
Anderson, K. D. Targeting recovery: priorities of the spinal cord-injured population. J Neurotrauma 21, 1371–1383 (2004).
Article PubMed Google Scholar
Nathan, C. & Ding, A. Nonresolving inflammation. Cell 140, 871–882 (2010).
Article CAS PubMed Google Scholar
DePaul, M. A. et al. Intravenous multipotent adult progenitor cell treatment decreases inflammation leading to functional recovery following spinal cord injury. Sci Rep 5, 16795 (2015).
Article ADS CAS PubMed PubMed Central Google Scholar
Giménez y Ribotta, M. et al. Oxysterol (7 beta-hydroxycholesteryl-3-oleate) promotes serotonergic reinnervation in the lesioned rat spinal cord by reducing glial reaction. J Neurosci Res 41, 79–95 (1995).
Article PubMed Google Scholar
DePaul, M. A., Lin, C.-Y., Silver, J. & Lee, Y.-S. Peripheral Nerve Transplantation Combined with Acidic Fibroblast Growth Factor and Chondroitinase Induces Regeneration and Improves Urinary Function in Complete Spinal Cord Transected Adult Mice. PLoS ONE 10, e0139335 (2015).
Article PubMed PubMed Central Google Scholar
Ramón y Cajal, S. Degeneration and Regeneration of the Nervous System (Oxford: Oxford UP, 1928).
David, S. & Aguayo, A. J. Axonal elongation into peripheral nervous system ‘bridges’ after central nervous system injury in adult rats. Science 214, 931–933 (1981).
Article ADS CAS PubMed Google Scholar
Munz, M., Rasminsky, M., Aguayo, A. J., Vidal-Sanz, M. & Devor, M. G. Functional activity of rat brainstem neurons regenerating axons along peripheral nerve grafts. Brain Res 340, 115–125 (1985).
Article CAS PubMed Google Scholar
Filous, A. R. et al. Immature astrocytes promote CNS axonal regeneration when combined with chondroitinase ABC. Dev Neurobiol 70, 826–841 (2010).
Article PubMed PubMed Central Google Scholar
Starkey, M. L., Bartus, K., Barritt, A. W. & Bradbury, E. J. Chondroitinase ABC promotes compensatory sprouting of the intact corticospinal tract and recovery of forelimb function following unilateral pyramidotomy in adult mice. Eur J Neurosci 36, 3665–3678 (2012).
Article PubMed PubMed Central Google Scholar
Jin, Y., Ziemba, K. S. & Smith, G. M. Axon growth across a lesion site along a preformed guidance pathway in the brain. Exp Neurol 210, 521–530 (2008).
Article PubMed Google Scholar
Ziemba, K. S., Chaudhry, N., Rabchevsky, A. G., Jin, Y. & Smith, G. M. Targeting axon growth from neuronal transplants along preformed guidance pathways in the adult CNS. Journal of Neuroscience 28, 340–348 (2008).
Article CAS PubMed Google Scholar
Lu, P. & Tuszynski, M. H. Growth factors and combinatorial therapies for CNS regeneration. Exp Neurol 209, 313–320 (2008).
Article CAS PubMed Google Scholar
Barritt, A. W. et al. Chondroitinase ABC promotes sprouting of intact and injured spinal systems after spinal cord injury. J Neurosci 26, 10856–10867 (2006).
Article CAS PubMed PubMed Central Google Scholar
Goshgarian, H. G. The crossed phrenic phenomenon: a model for plasticity in the respiratory pathways following spinal cord injury. J. Appl. Physiol. 94, 795–810 (2003).
Article PubMed Google Scholar
Ding, Y., Kastin, A. J. & Pan, W. Neural plasticity after spinal cord injury. Current pharmaceutical design, doi:10.2174/1381612053507855 (2005).
Iseda, T. et al. Spontaneous regeneration of the corticospinal tract after transection in young rats: a key role of reactive astrocytes in making favorable and unfavorable conditions for regeneration. Neuroscience 126, 365–374 (2004).
Article CAS PubMed Google Scholar
Liu, K. et al. PTEN deletion enhances the regenerative ability of adult corticospinal neurons. Nat Neurosci 13, 1075–1081 (2010).
Article CAS PubMed PubMed Central Google Scholar
Hurtado, A. et al. Robust CNS regeneration after complete spinal cord transection using aligned poly-L-lactic acid microfibers. Biomaterials 32, 6068–6079 (2011).
Article CAS PubMed PubMed Central Google Scholar
Ma, M., Wei, P., Wei, T., Ransohoff, R. M. & Jakeman, L. B. Enhanced axonal growth into a spinal cord contusion injury site in a strain of mouse (129X1/SvJ) with a diminished inflammatory response. J Comp Neurol 474, 469–486 (2004).
Article PubMed Google Scholar
Zukor, K. et al. Short hairpin RNA against PTEN enhances regenerative growth of corticospinal tract axons after spinal cord injury. Journal of Neuroscience 33, 15350–15361 (2013).
Article CAS PubMed PubMed Central Google Scholar
Smith, G. M., Miller, R. H. & Silver, J. Changing role of forebrain astrocytes during development, regenerative failure, and induced regeneration upon transplantation. J Comp Neurol 251, 23–43 (1986).
Article CAS PubMed Google Scholar
Du, K. et al. Pten Deletion Promotes Regrowth of Corticospinal Tract Axons 1 Year after Spinal Cord Injury. Journal of Neuroscience 35, 9754–9763 (2015).
Article CAS PubMed Google Scholar
Guest, J. D., Rao, A., Olson, L., Bunge, M. B. & Bunge, R. P. The ability of human Schwann cell grafts to promote regeneration in the transected nude rat spinal cord. Exp Neurol 148, 502–522 (1997).
Article CAS PubMed Google Scholar
Joosten, E. A., Bär, P. R. & Gispen, W. H. Collagen implants and cortico-spinal axonal growth after mid-thoracic spinal cord lesion in the adult rat. J Neurosci Res 41, 481–490 (1995).
Article CAS PubMed Google Scholar
Spilker, M. H. et al. The effects of tubulation on healing and scar formation after transection of the adult rat spinal cord. Restor Neurol Neurosci 18, 23–38 (2001).
CAS PubMed Google Scholar
Williams, R. R., Henao, M., Pearse, D. D. & Bunge, M. B. Permissive Schwann cell graft/spinal cord interfaces for axon regeneration. Cell Transplant 24, 115–131 (2015).
Article PubMed Google Scholar
Lee, Y.-S., Wu, S., Arinzeh, T. L. & Bunge, M. B. Enhanced noradrenergic axon regeneration into schwann cell-filled PVDF-TrFE conduits after complete spinal cord transection. Biotechnol. Bioeng., doi:10.1002/bit.26088 (2016).
Xu, X.-M., Guénard, V., Kleitman, N., Aebischer, P. & Bunge, M. B. A Combination of BDNF and NT-3 Promotes Supraspinal Axonal Regeneration into Schwann Cell Grafts in Adult Rat Thoracic Spinal Cord. Exp Neurol 134, 261–272 (1995).
Article CAS PubMed Google Scholar
Lee, Y.-S., Hsiao, I. & Lin, V. W. Peripheral nerve grafts and aFGF restore partial hindlimb function in adult paraplegic rats. J Neurotrauma 19, 1203–1216 (2002).
Article PubMed Google Scholar
Tsai, E. C., Krassioukov, A. V. & Tator, C. H. Corticospinal regeneration into lumbar grey matter correlates with locomotor recovery after complete spinal cord transection and repair with peripheral nerve grafts, fibroblast growth factor 1, fibrin glue, and spinal fusion. J. Neuropathol. Exp. Neurol. 64, 230–244 (2005).
Article PubMed Google Scholar
Guest, J. D. et al. Influence of IN-1 antibody and acidic FGF-fibrin glue on the response of injured corticospinal tract axons to human Schwann cell grafts. J Neurosci Res 50, 888–905 (1997).
Article CAS PubMed Google Scholar
Sofroniew, M. V. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 32, 638–647 (2009).
Article CAS PubMed PubMed Central Google Scholar
Meletis, K. et al. Spinal cord injury reveals multilineage differentiation of ependymal cells. Plos Biol 6, e182 (2008).
Article PubMed PubMed Central Google Scholar
Zhang, S. et al. Photochemical scar ablation in chronically contused spinal cord of rat. J Neurotrauma 24, 411–420 (2007).
Article PubMed Google Scholar
Geller, H. M. & Fawcett, J. W. Building a bridge: engineering spinal cord repair. Exp Neurol 174, 125–136 (2002).
Article PubMed Google Scholar
Zhang, S.-X., Huang, F., Gates, M. & Holmberg, E. G. Scar ablation combined with LP/OEC transplantation promotes anatomical recovery and P0-positive myelination in chronically contused spinal cord of rats. Brain Res 1399, 1–14 (2011).
Article CAS PubMed Google Scholar
Camand, E., Morel, M.-P., Faissner, A., Sotelo, C. & Dusart, I. Long-term changes in the molecular composition of the glial scar and progressive increase of serotoninergic fibre sprouting after hemisection of the mouse spinal cord. Eur J Neurosci 20, 1161–1176 (2004).
Article PubMed Google Scholar
Zurita, M. & Vaquero, J. Bone marrow stromal cells can achieve cure of chronic paraplegic rats: functional and morphological outcome one year after transplantation. Neurosci Lett 402, 51–56 (2006).
Article CAS PubMed Google Scholar
Coumans, J. V. et al. Axonal regeneration and functional recovery after complete spinal cord transection in rats by delayed treatment with transplants and neurotrophins. Journal of Neuroscience 21, 9334–9344 (2001).
CAS PubMed Google Scholar
Blackmore, M. G. et al. Krüppel-like Factor 7 engineered for transcriptional activation promotes axon regeneration in the adult corticospinal tract. Proc Natl Acad Sci USA 109, 7517–7522 (2012).
Article ADS CAS PubMed PubMed Central Google Scholar
Shen, Y. et al. PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration. Science 326, 592–596 (2009).
Article ADS CAS PubMed PubMed Central Google Scholar
Filbin, M. T. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat Rev Neurosci 4, 703–713 (2003).
Article CAS PubMed Google Scholar
Chang, H.-Y., Cheng, C.-L., Chen, J.-J. J. & de Groat, W. C. Serotonergic drugs and spinal cord transections indicate that different spinal circuits are involved in external urethral sphincter activity in rats. Am J Physiol Renal Physiol 292, F1044–53 (2007).
Article CAS PubMed Google Scholar
Chen, J. et al. The effect of the 5-HT2A/2C receptor agonist DOI on micturition in rats with chronic spinal cord injury. J Urol 189, 1982–1988 (2013).
Article CAS PubMed Google Scholar
Lang, B. T. et al. Modulation of the proteoglycan receptor PTPσ promotes recovery after spinal cord injury. Nature 518, 404–408 (2015).
Article ADS CAS PubMed Google Scholar

Download references

Acknowledgements

This project was supported by National Institutes of Health (NIH) grants NS069765 to Y.-S.L. and NS025713 to J.S., as well as a grant from the Craig Neilsen Foundation (λ297064) to Y.-S.L. and J.S. and a grant from the Hong Kong Spinal Cord Injury Foundation to J.S. We thank the Brumagin/Nelson Fund for continuing support as well as Unite 2 Fight Paralysis. We would like to acknowledge Nicholas Curtis and Noah Staton for their assistance in animal care, Nicholas Curtis for his assistance with metabolic cage data analysis, Brad Lang for his behavioral assessment assistance, and JingQiang (Bruce) You for his technical assistance. The authors thank the Spinal Cord Injury Research Training Program at Ohio State University for surgical and behavioral training and guidance. We would also like to acknowledge use of Leica SP8 confocal microscope in the Light Microscopy Imaging Facility at Case Western Reserve University made available through the Office of Research Infrastructure (NIH-ORIP) Shared Instrumentation Grant S10OD016164.

Author information

Authors and Affiliations

Case Western Reserve Univ., Dept. of Neurosciences, 10900 Euclid Ave., SOM E654, Cleveland, OH, 44106, USA
Marc A. DePaul & Jerry Silver
Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, 44195, USA
Ching-Yi Lin & Yu-Shang Lee

Authors

Marc A. DePaul
View author publications
You can also search for this author in PubMed Google Scholar
Ching-Yi Lin
View author publications
You can also search for this author in PubMed Google Scholar
Jerry Silver
View author publications
You can also search for this author in PubMed Google Scholar
Yu-Shang Lee
View author publications
You can also search for this author in PubMed Google Scholar

Contributions

M.A.D. and Y.-S.L. performed all surgeries and data analyses. M.A.D. performed behavior and urodynamic experiments. M.A.D., Y.-S.L., and C.L. performed all tissue processing, staining, and imaging. M.A.D., Y.-S.L., and J.S. contributed to study design, interpreted analyses, and wrote the manuscript. All authors discussed and helped prepare the manuscript.

Corresponding author

Correspondence to Yu-Shang Lee.

Ethics declarations

Competing Interests

The authors declare that they have no competing interests.

Additional information

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Cite this article

DePaul, M.A., Lin, CY., Silver, J. et al. Combinatory repair strategy to promote axon regeneration and functional recovery after chronic spinal cord injury. Sci Rep 7, 9018 (2017). https://doi.org/10.1038/s41598-017-09432-6

Download citation

Received: 10 January 2017
Accepted: 26 July 2017
Published: 21 August 2017
DOI: https://doi.org/10.1038/s41598-017-09432-6

This article is cited by

New insights into glial scar formation after spinal cord injury
- Amanda Phuong Tran
- Philippa Mary Warren
- Jerry Silver
Cell and Tissue Research (2022)
Low-pressure micro-mechanical re-adaptation device sustainably and effectively improves locomotor recovery from complete spinal cord injury
- Veronica Estrada
- Julia Krebbers
- Hans Werner Müller
Communications Biology (2018)
Glial Cells Shape Pathology and Repair After Spinal Cord Injury
- Andrew D. Gaudet
- Laura K. Fonken
Neurotherapeutics (2018)
Repairing the neural highway
- David Holmes
Nature (2017)

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.